Jacobs Levy Equity Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Jacobs Levy Equity Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-24,500	Closed	-$166K	–	1083
2019 Q3	$166K	Sell	24,500 -41,390	-63%	-$311K	﹤0.01%	862
2019 Q2	$613K	Buy	65,890 +14,700	+29%	+$170K	0.01%	712
2019 Q1	$711K	Buy	+51,190	New	+$585K	0.01%	728
2018 Q4	–	Sell	-41,908	Closed	-$530K	–	1100
2018 Q3	$530K	Sell	41,908 -1,800	-4%	-$21.7K	0.01%	764
2018 Q2	$576K	Buy	43,708 +28,000	+178%	+$335K	0.01%	771
2018 Q1	$214K	Sell	15,708 -19,100	-55%	-$197K	﹤0.01%	915
2017 Q4	$207K	Sell	34,808 -84,913	-71%	-$583K	﹤0.01%	902
2017 Q3	$888K	Sell	119,721 -6,299	-5%	-$52.4K	0.02%	606
2017 Q2	$1.18M	Buy	126,020 +30,099	+31%	+$221K	0.03%	541
2017 Q1	$698K	Hold	95,921	–	–	0.01%	618
2016 Q4	$710K	Sell	95,921 -36,800	-28%	-$265K	0.01%	618
2016 Q3	$802K	Sell	132,721 -17,600	-12%	-$83.2K	0.01%	616
2016 Q2	$675K	Buy	150,321 +5,008	+3%	+$18.8K	0.01%	679
2016 Q1	$362K	Buy	+145,313	New	+$529K	0.01%	816
2015 Q1	–	Sell	-19,732	Closed	-$135K	–	909
2014 Q4	$135K	Buy	+19,732	New	+$104K	﹤0.01%	767

Other funds holding CCXI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Jacobs Levy Equity Management's CCXI Position: Q4 2019 in Review

Jacobs Levy Equity Management sold out of ChemoCentryx, Inc. (CCXI) in Q4 2019, closing a stake of 24,500 shares — an estimated $166K sold.

Jacobs Levy Equity Management first reported a position in CCXI in Q4 2014 and held it in 15 quarters. The position peaked at $1.18M in Q2 2017. 126 funds tracked by Wall St. Rank hold CCXI as of Q4 2019.

Jacobs Levy Equity Management reported no remaining ChemoCentryx, Inc. position as of Q4 2019 after selling out during the quarter.
Jacobs Levy Equity Management sold 24,500 ChemoCentryx, Inc. shares in Q4 2019, an estimated $166K.
Jacobs Levy Equity Management first reported a position in ChemoCentryx, Inc. in Q4 2014 and held it in 15 quarters.
Jacobs Levy Equity Management's ChemoCentryx, Inc. position peaked at $1.18M in Q2 2017.
126 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2019.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2019, filed 14 Feb 2020.